SOFTASO Trademark

Trademark Overview

On Friday, December 15, 2023, a trademark application was filed for SOFTASO with the United States Patent and Trademark Office. The USPTO has given the SOFTASO trademark a serial number of 98317206. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, April 22, 2025. This trademark is owned by United Therapeutics Corporation. The SOFTASO trademark is filed in the Medical Instrument Products category with the following description:

Nebulizers and inhalers for administering medication in the form of a mist inhaled into the lungs, for treatment of pulmonary hypertension and heart and lung diseases
softaso

General Information

Serial Number98317206
Word MarkSOFTASO
Filing DateFriday, December 15, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, April 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements

Goods and ServicesNebulizers and inhalers for administering medication in the form of a mist inhaled into the lungs, for treatment of pulmonary hypertension and heart and lung diseases

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Friday, December 15, 2023NEW APPLICATION ENTERED
Wednesday, May 22, 2024ASSIGNED TO EXAMINER
Thursday, May 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2024NON-FINAL ACTION E-MAILED
Thursday, May 23, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 27, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, August 27, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, August 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 22, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 22, 2025SOU EXTENSION 1 FILED
Tuesday, April 22, 2025SOU EXTENSION 1 GRANTED
Tuesday, April 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

softaso pulmonary treatment hypertension heart diseases lung lungs inhaled administering inhalers